Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabrina M Ronen

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
NMR in Biomedicine|January 19, 2012
Metabolic consequences of treatment with AKT inhibitor perifosine in breast cancer cellsJudy S Su, Sarah M Woods, Sabrina M Ronen
Breast Cancer Research : BCR|October 16, 2010
17-allyamino-17-demethoxygeldanamycin treatment results in a magnetic resonance spectroscopy-detectable elevation in choline-containing metabolites associated with increased expression of choline transporter SLC44A1 and phospholipase A2Alissa H Brandes, Christopher S Ward, Sabrina M Ronen
Molecular Cell|June 13, 2017
Autophagy-Dependent Shuttling of TBC1D5 Controls Plasma Membrane Translocation of GLUT1 and Glucose UptakeSrirupa Roy, Andrew M Leidal, Jordan Ye, et al.
Magnetic Resonance in Medicine|September 26, 2008
Macromolecular dynamic contrast-enhanced (DCE)-MRI detects reduced vascular permeability in a prostate cancer bone metastasis model following anti-platelet-derived growth factor receptor (PDGFR) therapy, indicating a drop in vascular endothelial growth factor receptor (VEGFR) activationHagit Dafni, Sun-Jin Kim, James A Bankson, et al.
Cell|May 27, 2014
Protein and nucleotide biosynthesis are coupled by a single rate-limiting enzyme, PRPS2, to drive cancerJohn T Cunningham, Melissa V Moreno, Alessia Lodi, et al.
NMR in Biomedicine|December 3, 2011
Vascular patterning and permeability in prostate cancer models with differing osteogenic propertiesHagit Dafni, Andrew J Burghardt, Sharmila Majumdar, et al.
Plos One|May 14, 2013
Early Chk1 phosphorylation is driven by temozolomide-induced, DNA double strand break- and mismatch repair-independent DNA damageMotokazu Ito, Shigeo Ohba, Karin Gaensler, et al.
Plos One|April 30, 2013
HDAC inhibition induces increased choline uptake and elevated phosphocholine levels in MCF7 breast cancer cellsChristopher S Ward, Pia Eriksson, Jose L Izquierdo-Garcia, et al.
Plos One|March 2, 2013
Pyruvate kinase M2 expression, but not pyruvate kinase activity, is up-regulated in a grade-specific manner in human gliomaJoydeep Mukherjee, Joanna J Phillips, Shichun Zheng, et al.
Molecular Cancer Therapeutics|August 30, 2008
Fatty acid synthase inhibition results in a magnetic resonance-detectable drop in phosphocholineJames Ross, Amer M Najjar, Madhuri Sankaranarayanapillai, et al.
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
NMR in Biomedicine|January 19, 2012
Metabolic consequences of treatment with AKT inhibitor perifosine in breast cancer cellsJudy S Su, Sarah M Woods, Sabrina M Ronen
Breast Cancer Research : BCR|October 16, 2010
17-allyamino-17-demethoxygeldanamycin treatment results in a magnetic resonance spectroscopy-detectable elevation in choline-containing metabolites associated with increased expression of choline transporter SLC44A1 and phospholipase A2Alissa H Brandes, Christopher S Ward, Sabrina M Ronen
Molecular Cell|June 13, 2017
Autophagy-Dependent Shuttling of TBC1D5 Controls Plasma Membrane Translocation of GLUT1 and Glucose UptakeSrirupa Roy, Andrew M Leidal, Jordan Ye, et al.
Magnetic Resonance in Medicine|September 26, 2008
Macromolecular dynamic contrast-enhanced (DCE)-MRI detects reduced vascular permeability in a prostate cancer bone metastasis model following anti-platelet-derived growth factor receptor (PDGFR) therapy, indicating a drop in vascular endothelial growth factor receptor (VEGFR) activationHagit Dafni, Sun-Jin Kim, James A Bankson, et al.
Cell|May 27, 2014
Protein and nucleotide biosynthesis are coupled by a single rate-limiting enzyme, PRPS2, to drive cancerJohn T Cunningham, Melissa V Moreno, Alessia Lodi, et al.
NMR in Biomedicine|December 3, 2011
Vascular patterning and permeability in prostate cancer models with differing osteogenic propertiesHagit Dafni, Andrew J Burghardt, Sharmila Majumdar, et al.
Plos One|May 14, 2013
Early Chk1 phosphorylation is driven by temozolomide-induced, DNA double strand break- and mismatch repair-independent DNA damageMotokazu Ito, Shigeo Ohba, Karin Gaensler, et al.
Plos One|April 30, 2013
HDAC inhibition induces increased choline uptake and elevated phosphocholine levels in MCF7 breast cancer cellsChristopher S Ward, Pia Eriksson, Jose L Izquierdo-Garcia, et al.
Plos One|March 2, 2013
Pyruvate kinase M2 expression, but not pyruvate kinase activity, is up-regulated in a grade-specific manner in human gliomaJoydeep Mukherjee, Joanna J Phillips, Shichun Zheng, et al.
Molecular Cancer Therapeutics|August 30, 2008
Fatty acid synthase inhibition results in a magnetic resonance-detectable drop in phosphocholineJames Ross, Amer M Najjar, Madhuri Sankaranarayanapillai, et al.
Pageof 8